Computational and pharmacological investigation of novel 1,5-diaryl-1,4-pentadien-3-one derivatives for analgesic, anti-inflammatory and anticancer potential

Document Type : Original Article


1 Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan

2 LaBioMMi, Department of Chemistry, Federal University of São Carlos, CP 676, 13.565-905, São Carlos, SP, Brazil

3 Department of Chemistry, Woman University Swabi, Guloo Dehri, Topi Road, 23340 Swabi, KPK, Pakistan

4 Basic Sciences Department, College of Science and Health Professions-(COSHP-J) King Saud bin Abdulaziz University for Health Sciences, Jeddah, Kingdom of Saudi Arabia


Objective(s): The novel 1,5-diaryl-1,4-pentadien-3-one derivatives were studied for analgesic, anti-inflammatory and anticancer potential to establish their role in pain, inflammatory disorders and cancer.
Materials and Methods: Two 1,5- diaryl-1,4-pentadien-3-one derivatives: (1E,4E)- 5-(4-fluoro phenyl)-1-(4-methoxyphenyl)- 2-methylpenta-1,4-dien-3-one (A2K2A17) and  (1E,4E)-5-(4-nitrophenyl)-1-(4-nitrophenyl)-2-ethylhexa-1,4-dien-3-one (A11K3A11) were synthesized and characterized via 1H NMR and 13C NMR techniques. Molecular docking, anti-inflammatory, analgesic and anticancer activities were performed using Auto Doc Vina, carrageenan mediated paw edema and formalin induced chronic inflammation, acetic acid induced writhings and hotplate assay and brine-shrimp lethality assay.
Results: A2K2A17 and A11K3A11 showed high computational affinities (binding energy > -9.0 Kcal/mol) against COX-1, kappa receptor and braf kinase domain. A2K2A17 and A11K3A11 exhibited moderate docking affinities (binding energy > -8.0 Kcal/mol) against COX-2, human capsaicin receptor, tumor necrosis factor, lipoxygenase, colony stimulating factor, delta receptor, cyclin dependent protein kinase-2, mitogen activated kinase, mu receptor and kit kinase domain. A2K2A17 and A11K3A11 possess low docking affinities (binding energy > -7.0 Kcal/mol) against purinoceptor, platelets-derived growth Factor-1 and vascular-endothelial growth factor. In analgesic activity, A2K2A17 (1-30 mg/kg) and A11K3A11 (1-10 mg/kg) decreased acetic acid induced writhes and prolonged the latency time (P<0.01, PConclusion: The in silico, in vitro and in vivo studies on A2K2A17 and A11K3A11 reports their computational binding affinities against targets as well as the analgesic, anti-inflammatory and the anticancer effects.


Main Subjects

1. Loeser JD, Melzack R. Pain: an overview. The Lancet 1999; 353:1607-1609.
2. Zulfiker AHM, Rahman MM, Hossain MK, Hamid K,  Mazumder MEH, Rana MS. In vivo analgesic activity of ethanolic extracts of two medicinal plants-Scoparia dulcis L. and Ficus racemosa Linn. Biol Med 2010; 2:42-48.
3. Vane J, Botting R. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44:1-10.
4. Perianayagam JB, Sharma S, Pillai K. Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals. J Ethnopharmacol 2006; 104:410-414.
5. Yeşilada E, Üstün O, Sezik E, Takaishi Y, Ono Y, Honda G. Inhibitory effects of Turkish folk remedies on inflammatory cytokines: interleukin-1α, interleukin-1β and tumor necrosis factor α. J Ethnopharmacol 1997; 58:59-73.
6. Li RW, Myers SP, Leach DN, Lin GD, Leach G. A cross-cultural study: anti-inflammatory activity of Australian and Chinese plants. J Ethnopharmacol 2003; 85:25-32.
7. Dharmasiri MG, Jayakody JRAC, Galhena G, Liyanage SSP, Ratnasooriya WD. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo. J Ethnopharmacol 2003; 87:199-206.
8. Park JH, Son KH, Kim SW, Chang HW, Bae K,  Kang, SS et al. Anti-inflammatory activity of Synurus deltoides. Phytother Res 2004; 18:930-933.
9. Amin KM, Eissa AA, Abou-Seri SM, Awadallah FM, Hassan GS. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as anti-tumor agents. Eur J Med Chem 2013; 60:187-198.
10. Cabrera M, Simoens M, Falchi G, Lavaggi ML, Piro OE, Castellano EE et al. Synthetic chalcones, flavanones, and flavones as antitumoral agents: Biological evaluation and structure–activity relationships. Bioorganic Med Chem 2007; 15:3356-3367.
11. Anto RJ, Sukumaran K, Kuttan G, Rao MNA, Subbaraju V, Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett 1995; 97:33-37.
12. Elias D, Beazely M, Kandepu N. Bioactivities of chalcones. Curr Med Chem 1999; 6:1125-1149.
13. Araico A, Terencio MC, Alcaraz MJ, Dominguez JN, León C, Ferrándiz ML. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor. Life Sci 2007; 80:2108-2117.
14. Din ZU, Fill TP, de Assis FF, Lazarin-Bidóia D, Kaplum V, Garcia FP et al. Unsymmetrical 1, 5-diaryl-3-oxo-1, 4-pentadienyls and their evaluation as antiparasitic agents. Bioorganic Med Chem 2014; 22:1121-1127.
15. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Medica 1982; 5:31-34.
16. Ahmed F, Selim MST, Das AK, Choudhuri MSK. Anti-inflammatory and antinociceptive activities of Lippianodiflora Linn. Pharmazie 2004; 59:329-330.
17. Adzu B, Amos S, Kapu S, Gamaniel K. Anti-inflammatory and anti-nociceptive effects of Sphaeranthus senegalensis. J Ethnopharmacol 2003; 84:169-173.
18. Padilha MM, Vilela FC, Rocha CQ, Dias MJ, Soncini R, dosSantos MH et al.  Antiinflammatory properties of Morus nigra leaves. Phytother Res 2010; 24:1496-1500.
19. Ray SD, Ray S, Zia-Ul-Haq M,  DeFeo V, Dewanjee S. Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev (Rhamnaceae) as anti-inflammatory agent. BMC Complement Altern Med 2015; 15:1.
20. Cho AE, Guallar V, Berne BJ, Friesner R. Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach. J Comput Chem 2005; 26:915-931.
21. Bibi G, Ullah N, Mannan N, Mirza B. Antitumor, cytotoxic and antioxidant potential of Aster thomsonii extracts. Afr J Pharm Pharmacol 2011; 2:252-258.
22. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. InChemical Biology: Humana Press, New York, NY; 2015.p. 243-250.
23. Ayyappa B, Kanchi S, Singh P, Sabela MI, Dovey M, Bisetty K. Analytical evaluation of steviol glycosides by capillary electrophoresis supported with molecular docking studies. J Iran Chem Soc 2015; 12:127-136.
24. Gené RM, Segura L, Adzet T, Marin E, Iglesias J. Heterotheca inuloides: anti-inflammatory and analgesic effect. J Ethnopharmacol 1998; 60:157-162.
25. Bentley GA, Newton SH, Starr JB. Studies on the antinociceptive action of α‐agonist drugs and their interactions with opioid mechanisms. Br J Pharmacol 1983; 79:125-134.
26. Bukhari IA, Khan RA, Gilani AUH, Shah AJ, Hussain J, Ahmad VU. The analgesic, anti-inflammatory and calcium antagonist potential of Tanacetum artemisioides. Arch Pharm Res 2007; 30:303-312.
27. Burch RM, DeHaas C. A bradykinin antagonist inhibits carrageenan edema in rats.  Naunyn-Schmiedeberg’s Arch Pharmacol 1990; 342:189-193.
28. Selvam C, Jachak SM. A cyclo-oxygenase (COX) inhibitory bi flavonoids from seeds of Semecarpus anacardium. J Ethnopharmacol 2004; 95:209-212.
29. Grosser T, Smyth E, FitzGerald GA. Antiinflammatory, antipyretic and analgesic agents. In: Goodman LS, Gilman A, Brunton LL. The Pharmacological Basis of Therapeutics, 12th  ed. McGraw-Hill: New York; 2011.p. 959-971.
30. Igbe I, Ching FP, Eromon A. Anti-inflammatory activity of aqueous fruit pulp extract of Hunteria umbellata K. schum in acute and chronic inflammation. Acta Pol Pharm 2010; 67:81-85.